A1 Refereed original research article in a scientific journal

Effects of depressive symptoms and coronary heart disease and their interactive associations on mortality in middle-aged adults: The Whitehall II cohort study




AuthorsNabi H, Shipley MJ, Vahtera J, Hall M, Korkeila J, Marmot M, Kivimäki M, Singh-Manoux A

PublisherBMJ

Publication year2010

JournalHeart

Journal acronymHeart

Number in series20

Volume96

Issue20

First page 1645

Last page1650

Number of pages6

ISSN1355-6037

DOIhttps://doi.org/10.1136/hrt.2010.198507


Abstract

Background: Depression and mortality have been studied separately in patients with coronary heart disease (CHD) and in populations healthy at study inception. This does not allow comparisons across risk-factor groups based on the cross-classification of depression and CHD status.

Objective: To examine effects of depressive symptoms and CHD and their interactive associations on mortality in middle-aged adults followed over 5.6years.

Design and setting: A prospective population-based cohort study of 5936 middle-aged men and women from the British Whitehall II study. We created four risk-factor groups based on the cross-classification of depressive symptoms and CHD status.

Results: The age-adjusted and sex-adjusted hazard ratios for death from all causes were 1.67 (p<0.05) for participants with only CHD, 2.10 (p<0.001) for those with only depressive symptoms and 4.99 (p<0.001) for those with both CHD and depressive symptoms when compared to participants without either condition. The two latter risk-factor groups remained at increased risk after adjustments for relevant confounders. The relative excess risk due to the interaction between depressive symptoms and CHD for all-cause mortality was 3.58 (95% CI -0.09 to 7.26), showing some evidence of an additive interaction. A similar pattern was also observed for cardiovascular death.

Conclusions: This study provides evidence that depressive symptoms are associated with an increased risk of all-cause and cardiovascular death and that this risk is particularly marked in depressive participants with co-morbid CHD.



Last updated on 2024-26-11 at 10:48